Neuromuscular Disorders
Volume 19, Issue 11 , Page 800, November 2009

Drug screening for muscular dystrophy: From target to function toward patients, is anything lost?

Received 15 August 2009

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0960-8966(09)00591-4

doi:10.1016/j.nmd.2009.08.012

Neuromuscular Disorders
Volume 19, Issue 11 , Page 800, November 2009

Article Tools